Both our primary AML cell comparisons suggested that the protein levels of ALDH2 are increased in elderly AML patients; this was true both when comparing elderly low-risk and younger low-risk patients, and high-risk vs all low-risk patients. Here, ALDH2 is linked to acute myeloid leukemia.